Susanne Kaul

Paul Ehrlich Str. 51-59
Langen, NI 63225, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence-Based Medicine: Current Aspects 2026.

Factors for Success and Failure of Allergen Immunotherapy (AIT) Trial Design in the Light of Evidence-Based Medicine: Current Aspects 2026.

Journal: Allergy

Published: May 22, 2026

Low Api m 10 in Commercial Honeybee Venom AIT Products Fails to Induce Prominent Humoral Responses in BALB/c Mice.

Low Api m 10 in Commercial Honeybee Venom AIT Products Fails to Induce Prominent Humoral Responses in BALB/c Mice.

Journal: Journal of investigational allergology & clinical immunology

Published: December 11, 2025

The Minimal Clinically Important Difference in Allergen Immunotherapy: The Rocky Road Toward an Evidence-Based Value.

The Minimal Clinically Important Difference in Allergen Immunotherapy: The Rocky Road Toward an Evidence-Based Value.

Journal: Allergy

Published: September 17, 2025

Therapy Allergen Ordinance (TAO): The final stretch.

Therapy Allergen Ordinance (TAO): The final stretch.

Journal: Allergologie select

Published: September 01, 2025

European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations.

European Medicines Agency (EMA) commentary on EMA/CHMP Guideline on allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations.

Journal: British journal of clinical pharmacology

Published: February 24, 2025

Establishment of an ELISA-based in vitro test system to quantify the major honey bee venom allergen Api m 10 in crude bee venoms and therapy allergen products.

Establishment of an ELISA-based in vitro test system to quantify the major honey bee venom allergen Api m 10 in crude bee venoms and therapy allergen products.

Journal: Allergy

Published: June 09, 2024

DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy.

DGAKI and PEI in dialogue 2023: Diagnostics and allergen immunotherapy.

Journal: Allergologie select

Published: October 25, 2023

Introduction of General Chapters on standard methods for allergen quantification in the European Pharmacopoeia.

Introduction of General Chapters on standard methods for allergen quantification in the European Pharmacopoeia.

Journal: Allergy

Published: October 17, 2022

Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).

Development of Core Outcome Measures sets for paediatric and adult Severe Asthma (COMSA).

Journal: The European respiratory journal

Published: March 21, 2022

The method makes the extract: Comparative analysis of birch pollen allergen extracts.

The method makes the extract: Comparative analysis of birch pollen allergen extracts.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: December 06, 2021

A regulator's view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure.

A regulator's view on AIT clinical trials in the United States and Europe: Why successful studies fail to support licensure.

Journal: The Journal of allergy and clinical immunology

Published: November 18, 2021

Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.

Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report.

Journal: Allergy

Published: March 02, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026